Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
---|---|---|---|---|---|---|---|---|---|
UUS66989HAS7NOVARTIS CAP 20/50 | 6,34% | 0 | 65,04% | 2,75% | 2050-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
XXPNDNOVARTIS CAPITAL 15/45 | 5,66% | 0 | 84,19% | 4,00% | 2045-11-20 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
UUS66989HAH1NOVARTIS CAPITAL 14/44 | 5,52% | 0 | 89,57% | 4,40% | 2044-05-06 | 1,85 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
UUS66989HAR9NOVARTIS CAP 20/30 | 4,66% | 0 | 89,33% | 2,20% | 2030-08-14 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
XXPNCNOVARTIS CAPITAL 15/25 | 4,47% | 0 | 99,01% | 3,00% | 2025-11-20 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
UUS66989HAN8NOVARTIS CAPITAL 17/27 | 4,25% | 0 | 97,70% | 3,10% | 2027-05-17 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
XXS176904160NOVARTIS FIN. 18/38 | 3,99% | 0 | 79,96% | 1,70% | 2038-08-14 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
XXS176904119NOVARTIS FIN. 18/30 | 3,02% | 0 | 92,31% | 1,38% | 2030-08-14 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
XXS223599621NOVARTIS FI. 20/28 | 2,90% | 0 | 90,68% | 0,00% | 2028-09-23 | 1,85 B EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
XXS149282548NOVARTIS FIN. 16/28 | 2,56% | 0 | 93,72% | 0,63% | 2028-09-20 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
NNOJANOVARTIS FIN. 17/27 | 2,50% | 0 | 96,70% | 1,13% | 2027-09-30 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
XXS113472979NOVARTIS FIN. 14/26 | 2,44% | 0 | 98,69% | 1,63% | 2026-11-09 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Novartis Finance SA |
1,39% | 0 | 108,32% | 1,85% | 2049-06-18 | 190 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG | |
1,39% | 0 | 105,81% | 1,85% | 2040-06-18 | 280 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG | |
1,34% | 0 | 97,42% | 1,05% | 2035-05-11 | 325 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG | |
1,24% | 0 | 104,26% | 1,75% | 2034-06-16 | 645 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG | |
0,97% | 0 | 98,46% | 0,63% | 2029-11-13 | 550 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG | |
0,79% | 0 | 101,81% | 1,60% | 2027-06-18 | 650 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG | |
0,43% | 0 | 99,97% | 0,25% | 2025-05-13 | 500 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG | |
— | 0 | 103,54% | 1,65% | 2031-06-18 | 435 M CHF | 5 000,00 CHF | 5 000,00 CHF | Novartis AG | |
NNVS3904288Novartis Capital Corp. 3.7% 21-SEP-2042 | — | 4 M | 83,00% | 3,70% | 2042-09-21 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS5894398Novartis Capital Corp. 3.8% 18-SEP-2029 | — | 9,11 M | 97,67% | 3,80% | 2029-09-18 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS5894400Novartis Capital Corp. 4.2% 18-SEP-2034 | — | 13,01 M | 95,37% | 4,20% | 2034-09-18 | 1,1 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS4950565Novartis Capital Corp. 2.0% 14-FEB-2027 | — | 2,82 M | 96,08% | 2,00% | 2027-02-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS5894401Novartis Capital Corp. 4.7% 18-SEP-2054 | — | 1,84 M | 90,46% | 4,70% | 2054-09-18 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |
NNVS5894399Novartis Capital Corp. 4.0% 18-SEP-2031 | — | 2,97 M | 97,30% | 4,00% | 2031-09-18 | 850 M USD | 1 000,00 USD | 2 000,00 USD | Novartis Capital Corp. |